SREBF2 and esophageal squamous cell carcinoma: Mechanistically, TTPAL drives ESCC progression by orchestrating metabolic reprogramming through m5C-mediated stabilization of SREBP2 mRNA, which amplifies cholesterol biosynthesis and elevates intracellular cholesterol levels.